Looking for a naltrexone? Not a problem! Guaranteed Worldwide Shipping Discreet Package Low Prices 24/7/365 Customer Support 100% Satisfaction Guaranteed. Read More...
The FDA announced the approval of an new weight loss drug on Sept. 11, 2014. The drug name is Contrave.
Using two separate drugs to lose weight can be very effective there are combinations before the FDA now awaiting approval. When dealing with weight-loss and the individuals who go through it you should err to the side of caution and permit the FDA do its job and demand some investigation be done so that the public understands the side effects and perils associated with the medications before we drive them. Keep in mind that drug companies have been in business to make money and that they would say everything to keep people on his or her medications.
Researchers found that participants taking this drug for the year, dropped excess weight within one month and have kept the extra weight off through the 56 weeks in the study. Contrave is really a combination with the drugs naltrexone and bupropion, which seems to reflect a brand new trend of weight-loss drugs which are made up of more than one active ingredient, which can make them more effective and safer.
Combo-pilling will be the newest fad or even better the newest ahead under scrutiny and thus it is just more publicly known recently, comb-pilling for losing weight has been around since the eighties. The biggest reason that using a combination of pills is starting to become popular may be the fact that by right now there are not any long term prescription weight loss supplements that have been licensed by the FDA other than orlistat. The truly disturbing part is that doctors are prescribing these combinations of medications although some people might of the combinations are already rejected or have yet to be authorized by the FDA.
Seizures really are a side effect with Contrave and mustn't be taken in people who have seizure disorders. The drug may also raise blood pressure levels and heart rate, and must not be used in people who have a history of heart attack or stroke in the previous six months. Blood pressure and pulse should also be measured prior to starting the drug and throughout therapy using the drug.
The FDA also warned that Contrave can raise blood pressure and heart rate and must not used in patients with uncontrolled high blood pressure levels, and also by anyone with heart-related and cerebrovascular (circulation system dysfunction impacting the brain) disease. Patients having a history of heart attack or stroke in the previous six months, life-threatening arrhythmias, or congestive heart failure were excluded from the clinical trials. Those taking Contrave should have their heart-rate and pulse monitored regularly. In addition, because the compound includes bupropion, Contrave comes having a boxed warning to alert physicians and patients on the increased chance of suicidal thoughts and behaviors related to antidepressant drugs. The warning also notes that serious neuropsychiatric events happen to be reported in patients taking bupropion for stopping smoking.
BioCorRx, Inc.'s naltrexone implant is not any bigger than a thumb and it is inserted within the patient's skin by way of a 30-minute, non-invasive outpatient procedure produced by a medical professional. The implant is administered as part of BioCorRx, Inc.'s Start Fresh Program which is distributed in a number of states by independent rehabilitation facilities.